Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement | Reuters
Purdue Pharma files new bankruptcy plan for $7.4 billion opioid settlement | Reuters
NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.
The payments are aimed at resolving thousands of lawsuits alleging that the company's pain medication OxyContin caused a widespread opioid addiction crisis in the United States. The headline figure had been previously flagged by Purdue and its owners, members of the wealthy Sackler family.
Comments
Post a Comment